Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro, JJ. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro, JJ
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib prevalence as population ages
    As our population continues to age, prevalence of Afib is going to skyrocket, to a projected 5.6 to 15.9 million adults by 2050.  
  • AFib prevalence rate projection, 2050
    By 2050, it is estimated that 88% of Americans with atrial fibrillation will be age 65 and older.  
  • Median age AFib patient
    The median age of people with atrial fibrillation is about 75 years.  
  • Healthcare costs of atrial fibrillation
    Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations…  
  • AFib increases mortality risk
    Most importantly, AFib double the person’s risk of death and is the cause of nearly 100,000 deaths in the U.S. each year.